His nomination to head the HHS by President-elect Donald Trump on Thursday could bring sweeping changes to the way Washington, D.C., targets health issues.

As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide ...

The use of weight loss drugs without doctor's supervision is not advisable and can lead to serious side effects and ...

Rasheeda Bush and her son, Brian Bush, have together lost over 200 pounds using diabetes and weight loss medications.

GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...

Tori Spelling made headlines earlier this year when she revealed she used a pharmaceutical drug to lose the weight she’d ...

Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...

The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply lower Friday, after President-elect Donald Trump named Robert F. Kennedy Jr.

The company's revenue jumped 77% in Q3 to reach $401.6 million in Q3 2024, alongside a net income of $75.6 million. It now ...

GLP-1RA prescription trends, real-world effectiveness, and predictors for access and rationing were highlighted at ...

(Reuters) -Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone density, a ...

Eli Lilly (NYSE: LLY) sells a broad range of pharmaceuticals treating various diseases, but one portfolio in particular has ...